Propylthiouracil
Class
Antithyroid agents
Subclass
Thyroid peroxidase inhibitors
Substance name
Propylthiouracil
Common formulations
Tablet
Dosage and administration
Adults patients
Hyperthyroidism in patients with Graves' disease
Hyperthyroidism in patients with toxic multinodular goiter
Other off-label uses
Indications for use
Labeled indications
Adults
Children
Off-label indications
Adults
Safety risks
Boxed warnings
Agranulocytosis
Contraindications
A history of hypersensitivity to the drug
Warnings and precautions
Drug-induced liver injury
Vasculitis
Specific populations
Renal impairment
eGFR 20-50 mL/min/1.73 m²
eGFR 10-20 mL/min/1.73 m²
eGFR < 10 mL/min/1.73 m²
Renal replacement therapy
Continuous renal replacement
Intermittent hemodialysis
Peritoneal dialysis
Hepatic impairment
Any severity
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: C
Breastfeeding
Acceptable for use during breastfeeding.
Unknown drug levels in breastfed infants.
Unlikely to cause adverse effects in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Uncommon < 1%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource